The To understand, at the molecular level, how receptors allow cells to sense and respond to their external environment is a central goal of receptor research. This question can be approached by identifying the mechanism by which binding of a ligand to the extracellular portions of a receptor brings about an activated state of the receptor inside the cell membrane. However, a full understanding additionally requires quantitative information about the relationship between receptor occupancy, receptor activation, and downstream response. Insights at this level are becoming achievable for certain members of the large and diverse family of cytokine and growth factor receptors comprising two or more noncovalently associated subunits (1). A new mechanistic paradigm was introduced when it was proposed that certain of these receptors function by a mechanism of ligand-induced receptor dimerization (2), exemplified by the homodimeric receptor for human growth hormone (hGH-R) (3, 4), a class I cytokine receptor. This mechanism of receptor activation, illustrated in Fig. 1 , is believed to apply to a significant number of oligomeric receptors (1, 5) and, importantly, is simple enough to be amenable to detailed experimental and theoretical analysis. The simplicity of this mechanism promises insight into how the affinity of receptor for ligand, and of the receptor chains for each other upon the binding of ligand, is coupled to the sensitivity and dynamic range of the cellular response. Improving our understanding of these quantitative features of the activation mechanism is not only of theoretical interest; the affinity between receptor chains in the presence of bound ligand has important implications for the development of inhibitors that work by blocking the interaction between receptor chains. The binding affinity between receptor chains on the surface of cells cannot easily be determined by using soluble forms of the receptor chains, because of the difficulty of accounting for the entropic consequences of the reduction in dimensionality that occurs when a binding event is constrained to the two dimensions of a cell membrane. Consequently, no quantitative measure of the interaction affinity between receptor chains on the cell surface has yet been achieved.
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We describe here an approach that uses readily obtainable experimental data to derive an estimate of the interaction affinity between receptor chains brought about by the binding of ligand to the cell, using as an example the heterodimeric receptor for interleukin 4 (IL-4) (6) comprising the IL-4 receptor ␣ chain (IL-4R␣) and the common gamma chain (␥ c ) (7, 8) . This receptor belongs to a subfamily of class I cytokine receptors all of which use ␥ c , and that also includes receptor subunits for IL-2, IL-7, IL-9, and IL-15. Both IL-4R␣ and ␥ c are structurally and functionally related to hGH-R, and detailed structural models of a ternary complex between IL-4, IL-4R␣, and ␥ c have been constructed on the basis of this homology (9) . Mutational analysis of IL-4 supports a mechanism of ligand-induced receptor dimerization for its receptor (10) . Here, we confirm this mechanism for the IL-4 receptor on activated T cells by using a method based on monoclonal antibodies, and we use data for the binding of IL-4 to the receptor and its component subunits to estimate the affinity with which IL-4R␣ interacts with ␥ c on the cell membrane in the presence of bound IL-4. We show that this interaction is relatively weak, and that this property can be exploited by a noncompetitive inhibitor that blocks IL-4-dependent T cell proliferation without competing directly against IL-4 binding.
as described in ref. 11 . The T cell-enriched PBMC were cultured in a humidified incubator for 3 days at 37°C, 5% CO 2 at 10 6 cells͞ml in RPMI medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 units͞ml of penicillin, 100 g͞ml of streptomycin, and 1 g͞ml of phytohemagglutinin (PHA; Difco) to polyclonally activate T cells. The resulting PHA blasts were washed three times with fresh medium and recultured overnight at 10 6 cells͞ml in medium without PHA. The next day the rested cells were transferred to 96-well flat-bottom plates, and cultured at 5 ϫ 10 4 cells͞well with mAb (CP.B8, anti-IL-4R␣, or control Ig) at the specified concentrations. After 45 min at 37°C, recombinant human IL-4 (R & D Systems) was added to final concentrations of 0.015-100 ng͞ml. Cells were cultured for 40 hr, and proliferation was measured by the incorporation of 3 H-thymidine (Amersham), which was included during the last 16 hr of culture. Data were plotted as mean counts͞min from triplicate wells. For each dose-response curve, the concentration of IL-4 required to give a half-maximal response (EC 50 ) was determined by fitting the data to a standard four-parameter equation by nonlinear regression (DeltaGraph 3.5; DeltaPoint, Scotts Valley, CA).
Binding Studies. Cos-7 cells were transiently transfected by electroporation with a pCDM8 vector containing the cDNA sequence for full-length human IL-4R␣ (2 g) or full-length human ␥ c (20 g) (11), or cotransfected with IL-4R␣ (2 g) plus ␥ c (20 g). Additional cells were mock-transfected with vector alone for use as a control. The transfected cells were cultured for 2 days at 37°C, 5% CO 2 in DMEM supplemented with 10% fetal bovine serum (FBS) and 2 mM L-glutamine. PBMC were prepared and activated as described above, except that enrichment for T cells was omitted and PHA was used at 2 g͞ml. Binding measurements were performed on day 3 after activation. Cells (5 ϫ 10 5 transfected Cos-7 cells or 1.5 ϫ 10 6 PBMC) were incubated in 200 l PBS containing 1% FBS and 0-1 nM 125 I-labeled IL-4 (New England Nuclear) at ambient temperature. After 1 hr, shown in control experiments to be sufficient for binding to reach equilibrium, cells were washed twice with 2 ml of PBS containing 1% FBS, and radioactivity bound to the cells was quantified by using a Wallac 1470 gamma counter. The data were corrected for nonspecific binding, which was determined in each experiment from control measurements containing 100-fold excess of unlabeled IL-4 and was found to be a linear function of 125 I-IL-4 concentration. Specific counts bound were plotted as the average of duplicate measurements and were fitted by nonlinear regression to a simple hyperbolic equation representing a single site binding model.
RESULTS AND DISCUSSION
To probe the interaction between the IL-4R␣ and ␥ c receptor chains in the absence and presence of bound IL-4, we investigated the mechanisms by which the anti-␥ c mAb CP.B8 and a mAb directed against the IL-4R␣ chain block the function of the receptor on activated T cells. CP.B8 is specific for the extracellular portion of human ␥ c and inhibits the IL-4-dependent proliferation of PHA-activated T cells with an IC 50 of Ϸ75 g͞ml when tested at a single subsaturating concentration of IL-4 (11). The binding site for CP.B8 has been mapped (11) to a conformational epitope close to the junction of the two fibronectin type III-like domains that comprise the extracellular portion of the ␥ c molecule. Based on published structural models of the IL-4 receptor complex (9) , binding of CP.B8 to this position on ␥ c would be expected to block the interaction of ␥ c with IL-4 and possibly also with the IL-4R␣ chain. A Fab fragment of CP.B8 also blocks IL-4-dependent proliferation in this assay (11) . Fig. 2 shows dose-response curves for the ability of IL-4 to stimulate the proliferation of PHA-activated human T cells, measured at several fixed concentrations of anti-IL-4R␣ mAb or CP.B8. Under these conditions, secretion of growth-supporting cytokines is minimal, and addition of IL-4 induces proliferation that is essentially IL-4 dependent (11) . Fig. 2 A shows that the blocking mAb directed against the IL-4R␣ chain displays a competitive pattern of inhibition; inhibition is dose dependent, and the IL-4 dose-response curves are shifted to the right in proportion to the concentration of mAb ( Fig. 2 A, Inset). This result shows that the inhibitory effect of any given concentration of anti-IL-4R␣ mAb can be overcome, and the full proliferative response of the cells achieved, by increasing the IL-4 concentration to sufficiently high levels. In contrast, Fig. 2B shows that CP.B8 is a noncompetitive inhibitor of IL-4-dependent T cell proliferation; the EC 50 for IL-4 remains constant at Ϸ2 ng͞ml over the entire range of mAb concentrations (Fig. 2B , Inset), whereas the level of proliferation achieved at saturating concentrations of cytokine decreases with increasing CP.B8. Thus, a given concentration of CP.B8 inhibits by the same factor-relative to the uninhibited response seen at the same IL-4 concentration-over the entire IL-4 dose range, and inhibition cannot be overcome by increasing the IL-4 dose. Fig.  2D describes an experiment similar to that in Fig. 2B , demonstrating that a sufficiently high concentration of CP.B8 can block virtually all of the IL-4-dependent proliferative response of these cells (11) . This result shows that most or all of the response is mediated by ␥ c under these conditions and rules out the involvement of IL-13 receptor components, consistent with reports that such receptors are not expressed on activated T cells (12) . The inability of high concentrations of IL-4 to overcome inhibition by CP.B8 indicates that the mAb is not in direct competition with IL-4 for binding to the receptor. This finding is as expected for an antagonist that blocks the second step in receptor activation ( Fig. 1 ) by preventing the association between ␥ c and the binary IL-4R␣⅐IL-4 complex on the cell surface. This result additionally implies that the interaction affinity between the receptor chains at saturating IL-4 is low enough that IL-4R␣⅐IL-4 cannot effectively compete against the mAb for binding to ␥ c , otherwise receptor occupancy by IL-4 and CP.B8 would be mutually exclusive and inhibition by CP.B8 would appear competitive. Fig. 2D also shows that a CP.B8 Fab fragment gives a pattern of inhibition that is qualitatively similar to the noncompetitive inhibition seen with CP.B8 mAb. This result shows that the noncompetitive inhibition observed with CP.B8 requires only that it bind to ␥ c and block its participation in a productive complex; it does not require the ability to cross-link ␥ c molecules.
The noncompetitive mode of inhibition displayed by CP.B8 in Fig. 2B , supporting a sequential model of IL-4 receptor assembly, was further demonstrated by examining the effect of CP.B8 on IL-4 binding. (6, 14) . The filled symbols in Fig. 3B show that there is very little binding of IL-4 to unactivated PBMC, in agreement with published data that show a significant up-regulation of IL-4R␣ upon activation with PHA (14) . Fig. 4A shows that, as expected, the anti-IL-4R␣ antibody blocks binding of IL-4 to activated PBMC competitively with respect to IL-4. In contrast, experiments such as that shown in Fig. 4B showed that CP.B8 does not block binding at high levels of IL-4, even at a mAb concentration of 100 g͞ml, which inhibits IL-4-dependent proliferation by Ն50% (see Fig. 2 B and D) . CP.B8 does, however, appear to bring about a small decrease in the affinity of the cells for binding IL-4, consistent with a partial loss of the modest enhancement of affinity for IL-4 that ␥ c confers upon IL-4R␣. Taken together, the data in Figs. 2 and 4 provide strong evidence that the effect of CP.B8 is to block the recruitment of ␥ c into a ternary complex with IL-4 and the alpha chain. In so doing, these results provide confirmation that the IL-4 receptor comprising IL-4R␣ and ␥ c functions by a mechanism of ligand-induced receptor dimerization (10) .
Estimating the Interaction Affinity Between ␥ c and IL-4⅐IL-4R␣ on the Cell Surface. The sequential assembly of a heterodimeric receptor comprising receptor chains R 1 and R 2 , according to the mechanism of Fig. 1 , can be thought of in terms of a thermodynamic scheme in which the binding of ligand (L) to R 1 and the dimerization of R 1 and R 2 are considered as distinct processes that make up two orthogonal sides of a thermodynamic box (Scheme 1) (15). In the case of the IL-4 receptor, R 1 corresponds to IL-4R␣, R 2 to ␥ c , and L to IL-4. The key feature of Scheme 1 is its recognition that the overall equilibrium constant (designated K 5 ) for the binding of L to cells that express both R 1 and R 2 to produce R 1 ⅐L⅐R 2 complexes-i.e. for going from the bottom left corner to the top right corner of Scheme 1-constitutes one side of a closed thermodynamic cycle of which the binding of L to R 1 and the subsequent association of R 1 ⅐L with R 2 make up the other two 
A rigorous analysis of experimental binding data in terms of the thermodynamic relationships implied by Scheme 1 is complicated by the fact that the experimentally observed affinity for the binding of ligand to cells expressing both receptor chains, K D(App) , is only indirectly related to K 5 . The problem is one of dimensionality: the interaction between receptor chains on the cell surface is constrained to the two dimensions of the membrane, and thus K 2 has units of molecules͞m 2 . Similarly, the formation of ternary R 1 ⅐L⅐R 2 complexes upon the binding of ligand to cells expressing both R 1 and R 2 as nonpreassociated (i.e., independently diffusing) components is a termolecular process when taken overall, and K 5 has units of M.molecules͞m 2 , distinguishing it from K D(App) , which has units of M.
To circumvent this problem, expression levels of IL-4R␣ and ␥ c on PHA blasts were determined by flow cytometry, using a standard curve generated with calibrated beads that bind defined numbers of antibody molecules (data not shown). The results showed that IL-4R␣ is expressed at 1,000-1,600 copies͞ cell, while ␥ c is expressed at the Ϸ5-fold higher level of 5,000-8,500 copies͞cell. This finding, and the fact that the binding of IL-4 to PHA blasts is hyperbolic (Fig. 3B) 
Eq. 2 shows that K D(App) is a function of {R 2 } free , indicating that the apparent affinity for IL-4 binding to cells expressing both IL-4R␣ and ␥ c may vary from one cell type to another depending on the level of ␥ c expression. The Ϸ3-fold difference in K D(App) found for PHA blasts compared to cotransfected Cos-7 cells (Fig. 3) is an example of this effect. Furthermore, hyperbolic binding would not be expected unless R 2 is present in sufficient excess over R 1 such that free {R 2 } is not greatly decreased upon IL-4 binding to the cells (15) . This condition is met by the experimentally determined Ϸ5-fold excess of ␥ c over IL-4R␣, which establishes that the pool of free ␥ c is sufficient, in relation to the IL-4R␣ chain, that it is depleted by no more than about Ϸ20% upon binding of IL-4 to the cells. This result allows us to make the approximation that {R 2 } free is roughly constant over the entire IL-4 binding curve. The dissociation constant K 2 for the interaction between IL-4R␣⅐IL-4 and ␥ c on the cell surface can be described in terms of {R 2 } free and a dimensionless apparent association constant K R , as shown in Eq. 3.
Because {R 2 } free Ϸ constant in Fig. 3B , K R has a unique value on these cells that represents the equilibrium distribution of total IL-4R␣⅐IL-4 between the binary state, i.e. IL-4R␣⅐IL-4 itself, and the ternary state in which it has bound ␥ c to form the ternary complex IL-4R␣⅐IL-4⅐␥ c . Thus, K R represents the affinity of ␥ c for binding to IL-4R␣⅐IL-4. Because K R depends on the local or effective concentration of ␥ c (Eq. 3), it is not an intrinsic property of the receptor, as K 2 is, but depends on the level of expression of ␥ c , which is specific to the particular cell type-and sometimes to the specific cell populationunder study. The magnitude of K R can be estimated from experimental values for K 1 and K D(App) by combining Eqs. 1-3 to give the relationship shown in Eq. 4.
The affinity for IL-4 binding to Cos-7 cells transfected with IL-4R␣ alone (Fig. 3A) establishes that K 1 has a value of Ϸ600 pM (n ϭ 3; range ϭ 460-760 pM). Using K D(App) Ϸ 60 pM for the binding of IL-4 to activated PBMC (from Fig. 3B ), the relationship in Eq. 4 gives a value of K R Ϸ 9 for these cells. An earlier treatment of aggregating receptor systems, focusing on the analysis of curvature in Scatchard plots (16) , contains an equation that can be adapted to allow calculation of K R by an alternative approach. At the limit R 2 Ͼ Ͼ R 1 (under which condition Scatchard plots appear linear), application of this equation adapted from ref. 16 to our experimental data results in a value of K R Ϸ 9, identical to the value obtained above by using our method. The modest value we estimate for K R implies that, on PHA blasts, the affinity of ␥ c for binding to IL-4R␣⅐IL-4 is such that Fig. 5 shows that close to 50% receptor occupancy is required to achieve 50% of the maximal proliferation of activated T cells in response to IL-4, and that the response is affected by occupancy of even the last few percent of free receptor by IL-4. Thus, in mediating a dose-dependent modulation of heterodimeric receptor complexes from low residual levels to levels that involve Ϸ90% of the limiting receptor chain, the binding affinity between ␥ c and IL-4R␣⅐IL-4 is just sufficient to access essentially the full dynamic range that is available for signaling through the IL-4 receptor on these cells. The value of K R Ϸ 9 for the interaction between ␥ c and IL-4R␣⅐IL-4 suggests that these receptor components have evolved a binding affinity for each other that is strong enough-but no stronger than is necessary-to allow essentially all of the IL-4R␣ on the cell to form signaling complexes with ␥ c at saturating IL-4.
The finding that PHA blasts express 5,000-8,500 ␥ c molecules per cell allows us to estimate that {␥ c } Ϸ1-20 molecules͞ m 2 (assuming spherical cells of diameter Ϸ12 m and a membrane roughness that increases the surface area by a factor of 1-10). Eq. 3 thus gives a value for K 2 of roughly 0.1-2.0 molecules͞m 2 . Clearly, K 2 can be defined with much less precision than K R . Moreover, K R gives much more direct insight into the strength of the interaction between the receptor chains on the surface of the cell population at hand. Estimates obtained from radioligand binding data and from FACS analysis (data not shown) indicate that cotransfection of Cos-7 cells with IL-4R␣ and ␥ c (Fig. 3A) results in the expression of several-fold higher levels of ␥ c than is seen on PHA blasts. However, the much greater size of Cos-7 cells means that the surface density of ␥ c is probably significantly lower than on PHA blasts. This finding is consistent with the higher value of K D(App) measured for cotransfected Cos-7 cells (Fig. 3A, Eq. 2), and with the lower value of K R Ϸ 2 calculated from Eq. 4.
To determine whether the characteristics described above might be unique to the IL-4 receptor, the effect of CP.B8 on IL-2-dependent proliferation of PHA-activation T cells was tested. Activated T cells express IL-2 receptor ␣, ␤, and ␥ c (6, 7); however, IL-2R␣ and IL-2R␤ have been shown to exist as a preassociated complex (17) . Thus, activation of the IL-2 receptor can be thought of as a heterodimerization event in which the preassociated IL-2R␣͞␤ complex is the component responsible for the initial binding of IL-2, and activation of the receptor occurs upon the subsequent recruitment of ␥ c into an IL-2R␣͞␤⅐IL-2⅐␥ c complex (17) . A value of K R Ϸ 10 was calculated for the IL-2 receptor by using Eq. 4 together with K D(App) values for the binding of IL-2 to activated T cells (K D(App) Ϸ 10 pM) compared to cells expressing IL-2R␣ and IL-2R␤ but not ␥ c (K D Ϸ 100 pM) (7). This modest value for K R suggested that the binding of ␥ c to IL-2R␣͞␤⅐IL-2, like the interaction of the corresponding components of the IL-4 receptor, is relatively weak. This expectation was supported by experiments similar to those shown in Fig. 2D that showed that CP.B8 and its Fab fragment inhibit IL-2-dependent proliferation of activated T cells noncompetitively with respect to IL-2 (data not shown).
Mechanistic Differences Between Heterodimeric and Homodimeric Receptors. Homodimeric receptors (i.e. receptors in which R 1 and R 2 are identical) that are activated by a mechanism of ligand-induced receptor dimerization, such as hGH-R, possess the potential to give a bell-shaped doseresponse curve for activation by their natural ligand (4, 18, 19) . This tendency exists because very high ligand concentrations can potentially force the system into a state in which each receptor chain binds a separate ligand molecule, thus depleting the pool of free receptor available to be recruited into ternary R 1 ⅐L⅐R 1 complexes (4). This phenomenon is governed by Fig. 3B and text) . The solid line is an arbitrary interpolation of the data points. (A.W., unpublished data). Similarly, the homodimeric receptors for erythropoietin and for prolactin display broad effective dose ranges of 6 logs (19) and Ͼ6 logs (21), respectively. Although in some of these cases data were obtained by using transfected cells, and in some spare receptors may be partly responsible for broadening the effective dose range (4), the results nevertheless suggest that K R for these homodimeric receptors is relatively high. The relatively low affinities observed for binding of soluble receptor ectodomains to receptor͞ligand dimers in solution (3, 22) do not contradict this conclusion, but rather highlight the large entropic advantage that is conferred when the components are constrained to the cell surface. Although IL-4R␣ homodimerization can be induced by artificial means (23, 24) , the ability of IL-4 to induce these complexes appears unlikely (25) ; moreover, the heterodimeric composition of the receptor in our systems is supported by the data in Fig. 2D and by the hyperbolic form of the binding curves in Fig. 3 (16) . The potential for self-inhibition at high ligand concentrations does not exist for the IL-4R␣͞␥ c receptor, or for other heterodimeric receptors in which the ligand has an intrinsically very low affinity for binding to one of the two receptor chains. For heterodimeric receptors such as IL-4R there is therefore no obvious need for the affinity between receptor chains in the presence of bound ligand to exceed a value of K R Ϸ 10 that is sufficient to bring virtually all of the receptors into functional complexes upon the binding of ligand. It is, indeed, possible that the formation of a receptor complex that is relatively weak and rapidly dissociable may confer advantages for the regulation of receptor activity, especially in cases where a receptor chain is shared in common with other receptors of related function.
An implication of our results is that receptors such as IL-4R that possess a low K R in a given cellular context may be particularly amenable to pharmaceutical intervention using noncompetitive agents that block the second step in receptor activation. Because such inhibitors are not in direct competition with the natural ligand, which often binds its receptor with very high affinity, they may effectively inhibit receptor activation at high local concentrations of the activating ligand even if themselves possessing only moderate affinity for the receptor. Moreover, the level of inhibition achieved by such an agent will be independent of the concentration of the agonist cytokine, suggesting the possibility that a relatively low affinity drug might be loaded and maintained at an effective level, regardless of local or systemic up-regulation of ligand. Both of these properties are illustrated in Fig. 2 , for inhibition of IL-4-dependent T cell proliferation by CP.B8. Receptors displaying a high value of K R , and therefore possessing a high binding affinity between receptor chains once ligand has bound, are predicted to be less susceptible to inhibitors that work in this way.
